USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Cwm LLC

Cwm LLC lifted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 21.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,543 shares of the company’s stock after acquiring an additional 276 shares during the quarter. Cwm LLC’s holdings in USANA Health Sciences were worth $75,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Quest Partners LLC bought a new position in USANA Health Sciences during the 4th quarter valued at $66,000. Trexquant Investment LP acquired a new position in USANA Health Sciences during the fourth quarter worth about $266,000. Louisiana State Employees Retirement System bought a new stake in USANA Health Sciences in the fourth quarter worth about $300,000. Summit Global Investments acquired a new position in shares of USANA Health Sciences in the 4th quarter worth approximately $307,000. Finally, Harbor Capital Advisors Inc. raised its holdings in shares of USANA Health Sciences by 32.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 6,282 shares of the company’s stock worth $337,000 after purchasing an additional 1,547 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Stock Performance

Shares of NYSE:USNA opened at $45.57 on Monday. The firm has a 50 day simple moving average of $46.07 and a 200 day simple moving average of $48.16. USANA Health Sciences, Inc. has a 52 week low of $41.45 and a 52 week high of $69.60. The company has a market cap of $868.11 million, a PE ratio of 14.20, a price-to-earnings-growth ratio of 1.37 and a beta of 0.93.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, April 30th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.17. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The company had revenue of $227.80 million during the quarter, compared to analyst estimates of $223.27 million. On average, equities analysts predict that USANA Health Sciences, Inc. will post 2.78 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, DA Davidson cut their target price on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a research note on Tuesday, May 7th.

Insider Activity

In other USANA Health Sciences news, CFO G Doug Iiekking sold 5,198 shares of USANA Health Sciences stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total transaction of $232,662.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, major shareholder Myron W. Wentz sold 13,496 shares of the firm’s stock in a transaction that occurred on Friday, June 14th. The shares were sold at an average price of $45.03, for a total transaction of $607,724.88. Following the transaction, the insider now owns 7,864,345 shares of the company’s stock, valued at $354,131,455.35. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO G Doug Iiekking sold 5,198 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The disclosure for this sale can be found here. Insiders have sold 31,591 shares of company stock worth $1,458,098 in the last 90 days. Company insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.